Atlas Trials

Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypertension

Clinical trial NCT01508026 · COMPLETED

Trial details

NCT number
NCT01508026
Sponsor
Forest Laboratories
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Stage 1 HypertensionStage 2 Hypertension
Start date
2012-01-01
Primary completion
2013-03-01
Enrollment
4161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.